Czobor P, et al. - In this investigation, researchers characterized a large cohort of patients with amyloid cardiomyopathy from a community based, integrated healthcare system in terms of demographic, clinical, and laboratory features that correlated with mortality and heart failure hospitalization. Participants in the study were 198 patients diagnosed and treated in the Kaiser Permanente Northern California health care system who had a confirmed diagnosis of cardiac amyloidosis between 2001 and 2016. The authors concluded that coronary artery disease, diabetes mellitus, and high BNP levels were strongly linked to mortality in this population. Higher levels of B-type natriuretic peptide were associated with all-cause mortality.